Provided by Tiger Trade Technology Pte. Ltd.

Nuwellis, Inc.

0.9592
-0.0908-8.65%
Post-market: 0.96000.0008+0.08%17:55 EDT
Volume:667.59K
Turnover:686.99K
Market Cap:3.50M
PE:-0.01
High:1.06
Open:1.06
Low:0.9350
Close:1.05
52wk High:185.15
52wk Low:0.9350
Shares:3.65M
Float Shares:3.42M
Volume Ratio:1.76
T/O Rate:19.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-145.7988
EPS(LYR):-25.3816
ROE:-609.44%
ROA:-87.83%
PB:-1.70
PE(LYR):-0.04

Loading ...

Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules

THOMSON REUTERS
·
Jul 31

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Reuters
·
Jul 30

Nuwellis More than Doubles on Pediatric Study Acceptance

Reuters
·
Jul 30

Nuwellis Says Study Backs Epoprostenol as Alternative Anticoagulant for Pediatric Aquadex Ultrafiltration Therapy

Reuters
·
Jul 30

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy

THOMSON REUTERS
·
Jul 30

Top Premarket Gainers

MT Newswires Live
·
Jul 30

Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know

Benzinga Earnings
·
Jul 30

Nuwellis (NUWE) Stock Rallies 90% After Hours: Here's Why it is Trending

Benzinga Earnings
·
Jul 30

Nuwellis Expands Wisconsin Pediatric Footprint With Aquadex SmartFlow System

MT Newswires Live
·
Jul 28

Nuwellis Announces Preliminary Q2 Earnings With YoY Q2 Revenue Growth Of 14% And H2 Revenue Growth Of 20%

Benzinga Earnings
·
Jul 27

Nuwellis Sees Q2 2026 Revenue up 14%, H1 up 20% on Preliminary Results

Reuters
·
Jul 27

Nuwellis - Announces Preliminary H1 2026 Revenue Growth of 20% Year-Over-Year

THOMSON REUTERS
·
Jul 27

Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth

THOMSON REUTERS
·
Jul 27

Nuwellis Held Virtual Special Shareholder Meeting, 46.2% of Shares Represented

Reuters
·
Jul 25

Nuwellis awarded U.S. patent for Dual Lumen Catheter

TIPRANKS
·
Jul 16

Nuwellis Wins US Patent for Dual-lumen Catheter Used in Extracorporeal Therapies

Reuters
·
Jul 16

Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies

THOMSON REUTERS
·
Jul 16

Nuwellis - Awarded U.S. Patent for Dual Lumen Catheter on July 14, 2026

THOMSON REUTERS
·
Jul 16

Nuwellis Files Form 3 Initial Beneficial Ownership Statement for President, CEO Michael Kendrick Mccormick

Reuters
·
Jul 02

Nuwellis Inc trading halted, news pending

TIPRANKS
·
Jun 26